Drug class in one race
CTLA-4 / IL-2Rβγ drugs for Non-Small Cell Lung Cancer
2 tracked CTLA-4 / IL-2Rβγ drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the CTLA-4 / IL-2Rβγ page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
2 Phase 1/2